← Back to Screener
Alector, Inc. Common Stock (ALEC)
Price$2.71
Favorite Metrics
Price vs S&P 500 (26W)-23.65%
Price vs S&P 500 (4W)15.87%
Market Capitalization$298.53M
All Metrics
Book Value / Share (Quarterly)$0.28
P/TBV (Annual)1.97x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-45.99%
Cash Flow / Share (Quarterly)$-1.67
Price vs S&P 500 (YTD)60.61%
Net Profit Margin (TTM)-679.16%
EPS (TTM)$-1.39
10-Day Avg Trading Volume0.45M
EPS Excl Extra (TTM)$-1.39
Revenue Growth (5Y)-0.05%
EPS (Annual)$-1.39
ROI (Annual)-354.33%
Net Profit Margin (5Y Avg)-209.84%
Cash / Share (Quarterly)$2.32
Revenue Growth QoQ (YoY)-88.50%
ROA (Last FY)-48.74%
Revenue Growth TTM (YoY)-79.07%
EBITD / Share (TTM)$-1.33
ROE (5Y Avg)-146.33%
Operating Margin (TTM)-741.30%
Cash Flow / Share (Annual)$-1.67
P/B Ratio9.74x
P/B Ratio (Quarterly)5.56x
Net Income / Employee (Annual)$-1
EV / Revenue (TTM)11.52x
ROA (TTM)-41.03%
EV / EBITDA (TTM)5.48x
EPS Incl Extra (Annual)$-1.39
Current Ratio (Annual)3.83x
Quick Ratio (Quarterly)3.68x
3-Month Avg Trading Volume0.98M
52-Week Price Return162.78%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$1.93
P/S Ratio (Annual)14.19x
Asset Turnover (Annual)0.07x
52-Week High$3.40
Operating Margin (5Y Avg)-232.60%
EPS Excl Extra (Annual)$-1.39
CapEx CAGR (5Y)-61.74%
Tangible BV CAGR (5Y)53.15%
26-Week Price Return-14.90%
Quick Ratio (Annual)3.68x
13-Week Price Return38.92%
Total Debt / Equity (Annual)0.32x
Current Ratio (Quarterly)3.83x
Enterprise Value$242.418
Revenue / Share Growth (5Y)-5.51%
Asset Turnover (TTM)0.06x
Book Value / Share Growth (5Y)-39.32%
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-678.36%
Cash / Share (Annual)$2.32
3-Month Return Std Dev74.17%
Net Income / Employee (TTM)$-1
ROE (Last FY)-466.34%
EPS Basic Excl Extra (Annual)$-1.39
Receivables Turnover (TTM)74.61x
Total Debt / Equity (Quarterly)0.32x
EPS Incl Extra (TTM)$-1.39
Receivables Turnover (Annual)74.66x
ROI (TTM)-195.49%
P/S Ratio (TTM)14.19x
Pretax Margin (5Y Avg)-208.10%
Revenue / Share (Annual)$0.20
Tangible BV / Share (Annual)$2.59
Price vs S&P 500 (52W)127.69%
Year-to-Date Return64.74%
5-Day Price Return10.30%
EPS Normalized (Annual)$-1.39
ROA (5Y Avg)-23.30%
Net Profit Margin (Annual)-679.16%
Month-to-Date Return19.53%
Cash Flow / Share (TTM)$-1.58
EBITD / Share (Annual)$-1.33
Operating Margin (Annual)-741.30%
LT Debt / Equity (Annual)0.30x
ROI (5Y Avg)-122.63%
LT Debt / Equity (Quarterly)0.30x
EPS Basic Excl Extra (TTM)$-1.39
P/TBV (Quarterly)2.60x
P/B Ratio (Annual)5.56x
Pretax Margin (TTM)-678.36%
Book Value / Share (Annual)$0.28
Price vs S&P 500 (13W)36.05%
Beta0.70x
P/FCF (Annual)1.01x
Revenue / Share (TTM)$0.19
ROE (TTM)-224.96%
52-Week Low$0.90
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
2.54
2.54
2.54
2.69
Industry Peers — Biological Products(88)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
ALECAlector, Inc. Common Stock | 14.19x | -79.07% | — | — | $2.71 |
AMGNAmgen Inc | 5.20x | 9.95% | 73.30% | 2.93% | $350.16 |
GILDGilead Sciences Inc | 5.71x | 2.40% | 78.83% | 133.64% | $135.87 |
ARGXargenx SE American Depositary Shares | 12.59x | 89.56% | 150.91% | — | $834.45 |
BNTXBioNTech SE American Depositary Share | 9.06x | -11.81% | 84.21% | — | $105.19 |
BIIBBiogen Inc. Common Stock | 2.72x | 2.22% | 75.69% | -18.77% | $183.34 |
MRNAModerna, Inc. Common Stock | 10.91x | -39.93% | 70.32% | — | $54.59 |
NBIXNeurocrine Biosciences Inc | 4.64x | 21.45% | 98.18% | 2.31% | $131.59 |
EXELExelixis Inc | 4.89x | 6.85% | 96.39% | 31.10% | $43.61 |
TECHBio-Techne Corp. | 7.72x | 1.64% | 66.60% | -20.58% | $60.58 |
IBRXImmunityBio, Inc. Common Stock | 74.42x | 668.31% | 99.34% | — | $8.20 |
About
Alector Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for neurodegeneration. The company's approach focuses on restoring healthy immune function in the brain to counteract underlying pathologies. Its pipeline includes multiple therapeutic candidates, including AL001, AL002, AL003, and AL101.